Search Results - "TELENTI, A."

Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals by Rotger, M, Tegude, H, Colombo, S, Cavassini, M, Furrer, H, Décosterd, L, Blievernicht, J, Saussele, T, Günthard, H F, Schwab, M, Eichelbaum, M, Telenti, A, Zanger, U M

“…To assess the association of CYP2B6 allelic diversity with efavirenz (EFV) pharmacokinetics, we performed extensive genotyping of 15 relevant single nucleotide…”
Get full text

Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals by Arab‐Alameddine, M, Di Iulio, J, Buclin, T, Rotger, M, Lubomirov, R, Cavassini, M, Fayet, A, Décosterd, LA, Eap, CB, Biollaz, J, Telenti, A, Csajka, C

“…Besides CYP2B6, other polymorphic enzymes contribute to efavirenz (EFV) interindividual variability. This study was aimed at quantifying the impact of multiple…”
Get full text

A LC–tandem MS assay for the simultaneous measurement of new antiretroviral agents: Raltegravir, maraviroc, darunavir, and etravirine by Fayet, A., Béguin, A., Zanolari, B., Cruchon, S., Guignard, N., Telenti, A., Cavassini, M., Günthard, H.F., Buclin, T., Biollaz, J., Rochat, B., Decosterd, L.A.

“…Raltegravir (RAL), maraviroc (MVC), darunavir (DRV), and etravirine (ETV) are new antiretroviral agents with significant potential for drug interactions. This…”
Get full text

Pharmacogenetics of Anti-HIV Drugs by TELENTI, A, ZANGER, U. M

“…Pharmacogenetics holds promise in HIV treatment because of the complexity and potential toxicity of multidrug therapies that are prescribed for long periods…”
Get full text

Ageing with HIV: medication use and risk for potential drug-drug interactions by Marzolini, Catia, Back, David, Weber, Rainer, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Bernasconi, Enos, Khoo, Saye, Battegay, Manuel, Elzi, Luigia

“…Objectives To compare the use of co-medication, the potential drug-drug interactions (PDDIs) and the effect on antiretroviral therapy (ART) tolerability and…”
Get full text

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study by Greub, G, Ledergerber, B, Battegay, M, Grob, P, Perrin, L, Furrer, H, Burgisser, P, Erb, P, Boggian, K, Piffaretti, J-C, Hirschel, B, Janin, P, Francioli, P, Flepp, M, Telenti, A

“…Hepatitis C virus (HCV) infection is highly prevalent among HIV-1-infected individuals, but its contribution to the morbidity and mortality of coinfected…”
Get full text

Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry by COLOMBO, S, BEGUIN, A, TELENTI, A, BIOLLAZ, J, BUCLIN, T, ROCHAT, B, DECOSTERD, L. A

“…A sensitive and accurate liquid chromatography-tandem mass spectrometric (LC-MS/MS) method for the intracellular determination of nine antiretroviral drugs in…”
Get full text

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients by MARZOLINI, Catia, TELENTI, Amalio, DECOSTERD, Laurent, BIOLLAZ, Jérome, BUCLIN, Thierry

“…The results from our study on efavirenz, showing an association between plasma levels and treatment outcomes, were derived from a prospective observational…”
Get full text

Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study by Boubaker, K., Flepp, M., Sudre, P., Furrer, H., Haensel, A., Hirschel, B., Boggian, K., Chave, J.-P., Bernasconi, E., Egger, M., Opravil, M., Rickenbach, M., Francioli, P., Telenti, A.

“…The prevalence, clinical presentation, and risk factors for hyperlactatemia among patients receiving antiretroviral therapy was determined during a 1-month…”
Get full text

Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study by Ledergerber, Bruno, Telenti, Amalio, Egger, Matthias

Get full text

The relationship between the epigenetic aging biomarker “grimage” and lung function in both the airway and blood of people living with HIV: An observational cohort study by Hernández Cordero, Ana I, Yang, Chen Xi, Yang, Julia, Li, Xuan, Horvath, Steve, Shaipanich, Tawimas, MacIsaac, Julia, Lin, David, McEwen, Lisa, Kobor, Michael S., Guillemi, Silvia, Harris, Marianne, Lam, Wan, Lam, Stephen, Obeidat, Ma'en, Novak, Richard M., Hudson, Fleur, Klinker, Hartwig, Dharan, Nila, Montaner, Julio, Man, S.F. Paul, Kunisaki, Ken, Sin, Don D., Leung, Janice M., Baker, J.V., Duprez, D., Carr, A., Hoy, J., Dolan, M., Telenti, A., Grady, C., Matthews, G., Rockstroh, J., Belloso, W.H., Kagan, J.M., Wright, E., Brew, B., Price, R.W., Robertson, K., Cysique, L., Kunisaki, K.M., Connett, J.E., Niewoehner, D.E., Endpoint Review Committee, Lifson, A., Davey, R.T., Duprez, D., Gatell, J.M., Hoy, J., Pedersen, C., Prineas, R., Worley, J.

“…Age-related comorbidities such as chronic obstructive pulmonary disease (COPD) are common in people living with human immunodeficiency virus (PLWH). We…”
Get full text

HEV as a cause of acute hepatitis acquired in Switzerland by Christinet, M.F, Doerig, C, Moulin, H, Bihl, F, Brunner, F, Müllhaupt, B, Semela, D, Stickel, F, Beretta-Piccoli, B.T, Aubert, V, Telenti, A, Greub, G, Sahli, R, Moradpour, D

Get full text

Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection by Metzner, Karin J., Scherrer, Alexandra U., Preiswerk, Benjamin, Joos, Beda, von Wyl, Viktor, Leemann, Christine, Rieder, Philip, Braun, Dominique, Grube, Christina, Kuster, Herbert, Böni, Jürg, Yerly, Sabine, Klimkait, Thomas, Aubert, Vincent, Furrer, Hansjakob, Battegay, Manuel, Vernazza, Pietro L., Cavassini, Matthias, Calmy, Alexandra, Bernasconi, Enos, Weber, Rainer, Günthard, Huldrych F.

“…Background. Drug-resistant human immunodeficiency virus type 1 (HIV-1) minority variants (MVs) are present in some antiretroviral therapy (ART)-naive patients…”
Get full text

Population pharmacokinetic modelling and evaluation of different dosage regimens for darunavir and ritonavir in HIV-infected individuals by Arab-Alameddine, M, Lubomirov, R, Fayet-Mello, A, Aouri, M, Rotger, M, Buclin, T, Widmer, N, Gatri, M, Ledergerber, B, Rentsch, K, Cavassini, M, Panchaud, A, Guidi, M, Telenti, A, Décosterd, L A, Csajka, C

“…Darunavir is a protease inhibitor that is administered with low-dose ritonavir to enhance its bioavailability. It is prescribed at standard dosage regimens of…”
Get full text

Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study by Boillat-Blanco, Noémie, Darling, Katharine E A, Schoni-Affolter, Franziska, Vuichard, Danielle, Rougemont, Mathieu, Fulchini, Rosamaria, Bernasconi, Enos, Aouri, Manel, Clerc, Olivier, Furrer, Hansjakob, Günthard, Huldrych F, Cavassini, Matthias

“…Management of persistent low-level viraemia (pLLV) in patients on combined antiretroviral therapy (cART) with previously undetectable HIV viral loads (VLs) is…”
Get more information

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance by YERLY, S, VORA, S, RICKENBACH, M, HIRSCHEL, B, PERRIN, L, RIZZARDI, P, CHAVE, J.-P, VERNAZZA, P. L, FLEPP, M, TELENTI, A, BATTEGAY, M, VEUTHEY, A.-L, BRU, J.-P

“…To assess the impact of primary HIV infection (PHI) on the spread of HIV and the temporal trends in transmission of HIV drug resistance between 1996 and 1999…”
Get full text

A novel insertion element from Mycobacterium avium, IS1245, is a specific target for analysis of strain relatedness by GUERRERO, C, BERNASCONI, C, BURKI, D, BODMER, T, TELENTI, A

“…The insertion sequence IS1245 is a novel mycobacterial repetitive element identified in Mycobacterium avium. It encodes a transposase which exhibits a 64%…”
Get full text

Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV Infection by FENNER, Lukas, GAGNEUX, Sebastien, DOLINA, Marisa, CALMY, Alexandra, STUCKI, David, JATON, Katia, JANSSENS, Jean-Paul, MAZZA STALDER, Jesica, BODMER, Thomas, NINET, Beatrice, BÖTTGER, Erik C, EGGER, Matthias, HELBLING, Peter, BATTEGAY, Manuel, RIEDER, Hans L, PFYFFER, Gaby E, ZWAHLEN, Marcel, FURRER, Hansjakob, SIEGRIST, Hans H, FEHR, Jan

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

The evolutionary history of the CD209 (DC-SIGN) family in humans and non-human primates by Ortiz, M, Kaessmann, H, Zhang, K, Bashirova, A, Carrington, M, Quintana-Murci, L, Telenti, A

“…The CD209 gene family that encodes C-type lectins in primates includes CD209 (DC-SIGN), CD209L (L-SIGN) and CD209L2 . Understanding the evolution of these…”
Get full text

P701 AUTOCHTHONOUS ACUTE HEPATITIS E IN SWITZERLAND: INCREASED RATE OF SEVERE MANIFESTATION IN MEN >50 YEARS by Doerig, C, Moulin, H, Müllhaupt, B, Pache, I, Bihl, F, Telenti, A, Sahli, R, Moradpour, D

Get full text